XLONTATE
Market cap3.66bUSD
Dec 23, Last price
661.00GBP
1D
-1.78%
1Q
-0.60%
Jan 2017
-19.92%
Name
Tate & Lyle PLC
Chart & Performance
Profile
Tate & Lyle PLC, together with its subsidiaries, provides ingredients and solutions to the food, beverage, and other industries in the United States, the United Kingdom, other European countries, and internationally. It operates through three segments: Food & Beverage Solutions, Sucralose, and Primary Products. The company offers texturants; nutritive sweeteners, such as high fructose corn syrup and dextrose; health and wellness ingredients; and stabilizers. It also provides industrial starches for paper, packaging, and industrial adhesives; acidulants, such as citric acid; and commodities comprising corn gluten feed and meal for animal nutrition, as well as corn oil and ethanol. In addition, the company engages in the treasury and insurance businesses; and provision of research and development services. Tate & Lyle PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | 2015‑03 | |
Income | ||||||||||
Revenues | 1,647,000 -5.94% | 1,751,000 27.35% | 1,375,000 13.54% | |||||||
Cost of revenue | 1,196,000 | 1,301,000 | 1,077,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 451,000 | 450,000 | 298,000 | |||||||
NOPBT Margin | 27.38% | 25.70% | 21.67% | |||||||
Operating Taxes | 47,000 | 25,000 | 16,000 | |||||||
Tax Rate | 10.42% | 5.56% | 5.37% | |||||||
NOPAT | 404,000 | 425,000 | 282,000 | |||||||
Net income | 188,000 -1.05% | 190,000 -19.49% | 236,000 -6.72% | |||||||
Dividends | (76,000) | (570,000) | (144,000) | |||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | (25,000) | 499,000 | 58,000 | |||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 17,000 | 121,000 | 21,000 | |||||||
Long-term debt | 619,000 | 592,000 | 658,000 | |||||||
Deferred revenue | 44,000 | 49,000 | ||||||||
Other long-term liabilities | 113,000 | 123,000 | 142,000 | |||||||
Net debt | 6,000 | (14,000) | 519,000 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 208,000 | 118,000 | 137,000 | |||||||
CAPEX | (101,000) | (78,000) | (148,000) | |||||||
Cash from investing activities | (20,000) | 783,000 | (147,000) | |||||||
Cash from financing activities | (215,000) | (598,000) | (247,000) | |||||||
FCF | 347,000 | 1,596,000 | (214,000) | |||||||
Balance | ||||||||||
Cash | 437,000 | 475,000 | 110,000 | |||||||
Long term investments | 193,000 | 252,000 | 50,000 | |||||||
Excess cash | 547,650 | 639,450 | 91,250 | |||||||
Stockholders' equity | 831,000 | 782,000 | 1,213,000 | |||||||
Invested Capital | 1,393,350 | 1,324,550 | 2,326,750 | |||||||
ROIC | 29.73% | 23.28% | 13.31% | |||||||
ROCE | 23.01% | 22.57% | 12.07% | |||||||
EV | ||||||||||
Common stock shares outstanding | 404,200 | 411,400 | 403,200 | |||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | 545,000 | 545,000 | 378,000 | |||||||
EV/EBITDA | ||||||||||
Interest | 25,000 | 29,000 | 23,000 | |||||||
Interest/NOPBT | 5.54% | 6.44% | 7.72% |